Is Glycyrrhizin Powder approved by regulatory authorities?

Aug 12, 2025

Leave a message

Franklin Chen
Franklin Chen
Franklin oversees the research and development of organic plant-based products at Shaanxi JiuYuan Biotechnology. His focus is on creating sustainable solutions for food, pharmaceuticals, and cosmetics.

You're sourcing Glycyrrhizin Powder for a food, supplement, or pharmaceutical application. Before you commit to a supplier, you need a straight answer: is this ingredient actually approved?

The short answer is yes-with conditions. Glycyrrhizin holds GRAS status in the United States. It carries a defined upper intake limit in the European Union. China regulates it as a food additive under GB 2760. Each jurisdiction treats it differently, and those differences matter when you're building a compliance strategy.

The regulatory framework is nuanced. Dosage ceilings, population subgroups, and labeling requirements vary by market. Understanding these distinctions protects your brand and simplifies your path to commercialization.

Let's break down what regulators in major markets actually say about glycyrrhizin.

 

United States: GRAS Status and FDA Oversight

Licorice and glycyrrhiza hold Generally Recognized as Safe (GRAS) status in the United States. The FDA lists them under 21 CFR § 182.10 as GRAS for use in food as spices, natural seasonings, and flavorings. Licorice, glycyrrhiza, and ammoniated glycyrrhizin also appear under § 182.20 as GRAS for use as essential oils, oleoresins, and natural extractives.

This GRAS designation dates back to a regulation published in the Federal Register in January 1960. It was subsequently recodified and has remained in effect. The FDA's Select Committee on GRAS Substances conducted a comprehensive scientific literature review spanning 1920 to the present, examining chemical toxicity, metabolism, carcinogenicity, teratogenicity, and reproductive effects.

For B2B buyers, GRAS status means glycyrrhizin can be used in food with no limitation other than current good manufacturing practice. That's a broad allowance. It doesn't mean unlimited use is appropriate-it means the FDA considers glycyrrhizin safe under conditions of intended use.

Glycyrrhizin has also been nominated as a bulk drug substance for pharmacy compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. It is supplied as a crystalline powder, and each lot of raw material received must be accompanied by a valid Certificate of Analysis.

The practical takeaway: for US market entry, glycyrrhizin powder has a clear regulatory pathway. GRAS status supports food and supplement applications. For pharmaceutical compounding, additional documentation applies.

 

European Union: EFSA and the 100 mg/day Limit

The European Union takes a more prescriptive approach. The Scientific Committee on Food (SCF) and the European Food Safety Authority (EFSA) have evaluated glycyrrhizic acid and ammoniated glycyrrhizic acid for use as flavoring substances.

The SCF initially concluded in 1991 that available data were inadequate to derive an Acceptable Daily Intake (ADI). At that time, the Committee considered it prudent that regular ingestion should not exceed 100 mg/day, explicitly labeling this as a provisional figure.

New toxicological information, including human volunteer data, became available. The SCF revisited its position and concluded that while an ADI still cannot be derived, the 100 mg/day upper limit provides a sufficient level of protection for the majority of the population.

This upper limit covers intake of glycyrrhizinic acid from all sources-licorice confectionery, flavored products, and dietary supplements combined. The SCF also acknowledged that subgroups within the population might not receive sufficient protection at this level.

EFSA's Panel on Food Additives and Flavourings agreed with the SCF evaluation. The Panel noted that the maximum theoretical added maximum daily intake (mTAMDI) of 210 mg/person/day exceeds the 100 mg/person/day limit by a factor of two. This finding triggered a call for refined use levels and intake data.

For formulators targeting the EU market, the 100 mg/day ceiling is the operative constraint. Your product development must account for cumulative glycyrrhizin intake across all sources in the consumer's diet.

 

JECFA: The International Benchmark

The Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated glycyrrhizic acid and its ammonium salt. JECFA confirmed that consumption of glycyrrhizinic acid should not exceed 100 mg/day, equivalent to approximately 2 mg/kg body weight per day.

This international benchmark aligns with the EU position. JECFA's evaluation provides a globally recognized reference point for regulators in markets that lack their own comprehensive assessments.

The convergence between EFSA and JECFA on the 100 mg/day threshold gives B2B buyers a reliable parameter for product development. It simplifies your compliance strategy across multiple jurisdictions.

Is Glycyrrhizin Powder approved by regulatory authorities?

 

China: GB 2760-2024 and Specific Food Categories

China regulates glycyrrhizin salts under GB 2760-2024, the National Food Safety Standard for Food Additive Use. The regulated forms include ammonium glycyrrhizinate, monopotassium glycyrrhizinate, and tripotassium glycyrrhizinate.

The functional classification in China is sweetener (CNS number 19.012, 19.010, 19.025; INS number 958). This differs from the US approach, where glycyrrhizin is primarily classified as a flavoring agent.

China's standard specifies permitted food categories and maximum usage levels:

  • Preserved fruits and candied products (food category 04.01.02.08): Use as needed according to production requirements
  • Candies (05.02): Use as needed according to production requirements
  • Biscuits (07.03): Use as needed according to production requirements
  • Cured meat products (08.02.02, such as bacon and Chinese sausage): Maximum 0.2 g/kg, calculated as glycyrrhizic acid

The phrase "use as needed according to production requirements" reflects China's positive list approach. Specific categories permit flexible usage. Others, like cured meats, carry explicit numeric limits.

China also maintains separate standards for individual glycyrrhizin salts. GB 1886.240-2016 covers monopotassium glycyrrhizinate, GB 1886.242-2016 covers ammonium glycyrrhizinate, and GB 1886.241-2016 covers tripotassium glycyrrhizinate. These standards specify technical requirements, test methods, and quality specifications.

 

Safety Profile: What You Need to Know About Pseudoaldosteronism

Regulatory approval doesn't mean zero risk. Glycyrrhizin's primary safety concern is pseudoaldosteronism, a condition that mimics excessive aldosterone production.

At lower dosages or normal consumption levels, adverse reactions are rare. High doses of real licorice (greater than 1 ounce per day) and glycyrrhizin cause renal sodium and water retention. This can lead to elevated blood pressure. It also increases potassium excretion, potentially causing hypokalemia.

These effects matter for specific population subgroups. People with hypertension, heart disease, or kidney disease face elevated risk. Individuals taking digoxin or diuretics-medications that also increase potassium excretion-should avoid glycyrrhizin.

Pregnancy represents another consideration. Glycyrrhizin may exert steroid-like and estrogen-like effects. Heavy consumption during pregnancy may stimulate the fetal hypothalamic-pituitary-adrenal axis. Pregnant women should avoid licorice and glycyrrhizin products.

A National Cancer Institute-sponsored phase-1 clinical trial tested glycyrrhetic acid (the aglycone metabolite) in patients with a prior history of breast cancer. Ten healthy female volunteers received doses up to 500 mg/m². No significant toxicity was observed, and the compound was well tolerated.

The regulatory limits-100 mg/day in the EU and under JECFA guidance-exist precisely to keep intake below the threshold where pseudoaldosteronism becomes a concern for the general population.

 

What This Means for Your B2B Sourcing Strategy

You're sourcing Glycyrrhizin Powder for commercial use. Here's how to translate regulatory status into actionable procurement criteria.

Documentation Checklist for Suppliers

Your supplier should provide:

  • Certificate of Analysis (COA) for each batch, including assay by HPLC
  • Material Safety Data Sheet (MSDS) with hazard identification
  • Technical Data Sheet (TDS) with full specifications
  • Certificate of Origin (COO) confirming raw material source
  • Allergen statement and non-GMO statement
  • Heavy metal testing via ICP-MS (Pb, As, Cd, Hg)
  • Pesticide residue screening for multi-residue panels
  • Microbiological testing results (TPC, yeast/mold, E. coli, Salmonella)

The FDA nomination document for glycyrrhizin as a bulk drug substance explicitly states that a valid Certificate of Analysis must accompany each lot of raw material received. This isn't optional. It's an industry expectation.

Specifications to Verify

Parameter

Typical Standard

Why It Matters

Assay (HPLC)

≥95%, ≥98% glycyrrhizic acid

Determines potency and dosage accuracy

CAS Number

1405-86-3 (glycyrrhizin)

Identity confirmation

Appearance

White to light yellow powder

Visual quality check

Loss on Drying

≤5%

Prevents caking and microbial growth

Heavy Metals

Total <10 ppm; Pb <2 ppm; As <1 ppm

Regulatory compliance

Particle Size

95% through 80 mesh

Uniform mixing

Solubility

Soluble in water and ethanol

Application flexibility

Questions to Ask Your Supplier

  1. What is the exact glycyrrhizic acid content, and is it verified by HPLC?
  2. Can you provide a batch-specific COA for the lot I will receive?
  3. What is the country of origin for the raw licorice root?
  4. Is the product spray-dried or vacuum-dried?
  5. What certifications does your facility hold?
  6. Do you offer samples for formulation trials?
  7. What is your MOQ and lead time?

Red Flags

  • No batch-specific COA available
  • Glycyrrhizic acid content claimed without HPLC documentation
  • Vague answers about raw material origin
  • Pricing dramatically below market benchmarks
  • No retention samples or stability data

 

Quality Control: What a Reliable COA Should Cover

A comprehensive Certificate of Analysis for Glycyrrhizin Powder addresses:

Identity and Purity:

  • Assay by HPLC (glycyrrhizic acid content)
  • CAS number confirmation
  • Extract ratio or standardization basis
  • Plant part (root only)

Physical and Chemical:

  • Appearance and odor
  • Moisture content (Loss on Drying)
  • Ash content
  • Heavy metals (Pb, As, Cd, Hg)
  • Residual solvents

Microbiological:

  • Total plate count
  • Yeast and mold
  • E. coli, Salmonella, Staphylococcus aureus

Additional Testing:

  • Pesticide residues
  • Aflatoxins
  • Irradiation status (if applicable)

 

Choosing Jiuyuan Bio for Your Glycyrrhizin Powder Supply

Shaanxi Jiuyuan Biotechnology Co., Ltd. supplies bulk Glycyrrhizin Powder to food manufacturers, supplement brands, and pharmaceutical companies worldwide. Our facilities operate under cGMP and FSSC22000 frameworks, and we maintain ISO9001, ISO22000, HACCP, Kosher, and HALAL certifications.

We provide:

  • Glycyrrhizin Powder standardized to 95% and 98% by HPLC
  • Full COA with every batch, including heavy metals and microbiological testing
  • FDA registration and complete documentation for US market entry
  • Technical support for regulatory submissions and formulation development
  • Flexible MOQ starting at 1 kg
  • Samples for qualified B2B customers

Send your specification requirements to info@jiuybiotech.com. Our team responds within one business day with pricing, samples, and technical data sheets.

The regulatory pathway for Glycyrrhizin Powder is clear. The right supplier makes navigating it straightforward.

 

Frequently Asked Questions

1. Is Glycyrrhizin Powder FDA approved?

The FDA lists licorice and glycyrrhiza as GRAS (Generally Recognized as Safe) under 21 CFR § 182.10 and § 182.20. Glycyrrhizin is approved for use in food as a flavoring agent and flavor enhancer with no limitation other than current good manufacturing practice.

2. What is the maximum daily intake of glycyrrhizin in the EU?

The Scientific Committee on Food and EFSA set an upper limit of 100 mg/day for regular ingestion of glycyrrhizinic acid. This limit covers intake from all sources, including confectionery, flavored products, and supplements.

3. Can glycyrrhizin cause high blood pressure?

High doses of glycyrrhizin can cause renal sodium and water retention, potentially leading to elevated blood pressure and hypokalemia (pseudoaldosteronism). People with hypertension, heart disease, or kidney disease should avoid high-dose glycyrrhizin products.

4. Is glycyrrhizin approved in China?

Yes. China regulates glycyrrhizin salts under GB 2760-2024 as a sweetener. Permitted food categories include preserved fruits, candies, biscuits, and cured meats. Cured meats have a maximum usage limit of 0.2 g/kg calculated as glycyrrhizic acid.

5. What is the difference between glycyrrhizin and glycyrrhizic acid?

In common usage, the terms are interchangeable. Technically, glycyrrhizin is the glycoside of glycyrrhetic acid (also called glycyrrhizinic acid). Commercial products typically standardize to glycyrrhizic acid content.

6. Can Glycyrrhizin Powder be used in dietary supplements?

Yes. Glycyrrhizin has GRAS status in the US for food use, which includes dietary supplements. In the EU, supplement formulations must keep total glycyrrhizin intake below 100 mg/day. Always verify regulatory status in your target market.

7. What purity levels are available for Glycyrrhizin Powder?

Common commercial specifications include 95% and 98% glycyrrhizic acid by HPLC. Higher purity grades are available for pharmaceutical and research applications. Select the grade based on your formulation requirements and regulatory pathway.

8. How should Glycyrrhizin Powder be stored?

Store in a sealed container in a cool, dry environment away from direct sunlight and moisture. Glycyrrhizin Powder is hygroscopic and may cake if exposed to humidity. Under proper storage conditions, shelf life is typically 24 months.

 

References

  1. Isbrucker, R. A., & Burdock, G. A. (2006). Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regulatory Toxicology and Pharmacology, 46(3), 167–192.
  2. Scientific Committee on Food. (2003). Opinion of the Scientific Committee on Food on glycyrrhizinic acid and its ammonium salt. European Commission, Health & Consumer Protection Directorate-General.
  3. Joint FAO/WHO Expert Committee on Food Additives. (2004). Evaluation of certain food additives and contaminants. WHO Technical Report Series, No. 928.
  4. Hu, Y., Hou, J., Cai, Y., Ni, C., Xing, Z., Li, J., Zhou, Z., Xu, G., Zeng, X., & Jia, J. (2026). Therapeutic potential of glycyrrhizic acid in inflammation-related diseases: from HMGB1-oriented molecular insights to preclinical application. Archives of Pharmacal Research, 49(6), 820–862.
  5. Yu, J., Qu, H., Xu, W., Fang, Y., Wang, N., & Shi, W. (2026). Mechanisms and therapeutic potential of glycyrrhizic acid: Insights into key signaling pathways and disease modulation. Molecular Medicine Reports, 33(5), 126.
  6. Shane-McWhorter, L. (2025). Licorice. In MSD Manual Professional Edition. Merck & Co.
Send Inquiry
Send Inquiry